| B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) (NCT04897321) | St. Jude Children's Research Hospital | 2022-07-06 |
| Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy (NCT05322187) | RenJi Hospital | 2022-04-10 |
| Psychosocial Situation of Children With Rare Solid Abdominal Tumors and Their Families (NCT05245123) | Universitätsklinikum Hamburg-Eppendorf | 2022-02-21 |
| Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors (NCT05302921) | Children's National Research Institute | 2022-02-18 |
| Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors (NCT04337177) | Valent Technologies, LLC | 2021-10-25 |
| Diagnostic Efficacy and Prognostic Value of 18F-FDG PET/CT (MR) in Pediatric Solid Blastoma (NCT06190574) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2021-07-30 |
| A Prospective Multicenter Clinical Study of SCCG Protocol and ctDNA 5hmc in Predicting the Chemotherapy Sensitivity and Monitoring the Recurrence and Metastasis of Hepatoblastoma in Children and Adolescents (NCT07300449) | Sun Yat-sen University | 2021-06-23 |
| A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy (NCT04478292) | Shanghai Children's Medical Center | 2021-03-01 |
| Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors (NCT04315883) | Nemours Children's Clinic | 2021-02-11 |
| Deep Learning Magnetic Resonance Imaging Radiomics for Diagnostic Value of Hepatic Tumors in Infants (NCT05170282) | West China Hospital | 2021-01-01 |
| B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults (NCT04483778) | Seattle Children's Hospital | 2020-07-13 |
| T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR) (NCT04093648) | Baylor College of Medicine | 2020-01-01 |
| EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults (NCT03618381) | Seattle Children's Hospital | 2019-06-18 |
| PIVKA-II Combined With Alpha-Fetoprotein for Diagnostic and Prognostic Value of Hepatic Tumors in Infants (NCT03645655) | Shanghai Children's Medical Center | 2018-10-01 |
| Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery (NCT03533582) | Children's Oncology Group | 2018-05-24 |
| Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) (NCT03220035) | National Cancer Institute (NCI) | 2017-11-08 |
| Paediatric Hepatic International Tumour Trial (NCT03017326) | University of Birmingham | 2017-08-24 |
| Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors (NCT02867592) | National Cancer Institute (NCI) | 2017-05-18 |
| Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies (NCT04308330) | New York Medical College | 2017-03-17 |
| G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor (NCT02933333) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2016-09-27 |
| Combined Modality Therapy in Hepatoblastoma: South Egypt Cancer Institute Experience (NCT02557750) | Assiut University | 2016-01-01 |
| Molecular Basis of Pediatric Liver Cancer (NCT03959800) | University of Pittsburgh | 2015-06-22 |
| Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors (NCT02390843) | Emory University | 2015-02-01 |
| Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors (NCT02011126) | Children's Oncology Group | 2014-06-30 |
| Auto Transplant for High Risk or Relapsed Solid or CNS Tumors (NCT01505569) | Masonic Cancer Center, University of Minnesota | 2011-10-20 |
| Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors (NCT01331135) | Emory University | 2011-04-01 |
| A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB (NCT01125800) | Novartis Pharmaceuticals | 2011-02-01 |
| Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors (NCT00179816) | Ann & Robert H Lurie Children's Hospital of Chicago | 1999-04-01 |